Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.

This study has been completed.
Information provided by (Responsible Party):
Gerald M Reaven, Stanford University Identifier:
First received: February 4, 2013
Last updated: NA
Last verified: February 2013
History: No changes posted